One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...

Lilly's retatrutide shows remarkable weight loss in trials but raises concerns with side effects possibly linked to the drug like nausea and kidney stones. Read more here.

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

(Reuters) - Eli Lilly is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage ...

Weight loss medications like Wegovy and Zepbound are gaining popularity as millions turn to them for quick results and ...

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.